# Predictive Value of CHA2DS2VASC Score for Contrast-induced Nephropathy After Primary Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction Patients

> **NCT04730778** · — · COMPLETED · sponsor: **Cairo University** · enrollment: 500 (actual)

## Conditions studied

- Acute ST Segment Elevation Myocardial Infarction

## Interventions

- **DIAGNOSTIC_TEST:** serum creatinine and estimated glomerular filtration rate, on daily basis

## Key facts

- **NCT ID:** NCT04730778
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2022-12-15
- **Final completion:** 2023-04-15
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04730778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04730778, "Predictive Value of CHA2DS2VASC Score for Contrast-induced Nephropathy After Primary Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04730778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*